These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 6794183)

  • 41. Metabolic activation of aflatoxin B1: patterns of DNA adduct formation, removal, and excretion in relation to carcinogenesis.
    Essigmann JM; Croy RG; Bennett RA; Wogan GN
    Drug Metab Rev; 1982; 13(4):581-602. PubMed ID: 6813091
    [No Abstract]   [Full Text] [Related]  

  • 42. Interindividual differences in the activation of two hepatic carcinogens to mutagens by human liver.
    Harries GC; Boobis AR; Collier N; Davies DS
    Hum Toxicol; 1986 Jan; 5(1):21-6. PubMed ID: 3081427
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Metabolism of aflatoxin B1 (AFB1), aflatoxin G1 (AFG1) and vitamin C intake by guinea pig liver preparation in vitro.
    Domngang F; Emerole G
    Biochem Pharmacol; 1982 Jul; 31(14):2327-30. PubMed ID: 6812587
    [No Abstract]   [Full Text] [Related]  

  • 44. Inhibitory effect of ellagic acid on genotoxicity induced by aflatoxins B1 and G1.
    Górski T; Górska E; Odlanicki J; Sikora M
    IARC Sci Publ; 1991; (105):550-1. PubMed ID: 1906839
    [No Abstract]   [Full Text] [Related]  

  • 45. [Genotoxic and pathogenic effects of aflatoxin B1 in experiments on monkeys].
    Adzhigitov FI; Barta I; Gubeladze DA; Fomenko VN; Markova TN
    Vestn Akad Med Nauk SSSR; 1986; (3):48-51. PubMed ID: 3085370
    [No Abstract]   [Full Text] [Related]  

  • 46. Differences in the effect of phenobarbital treatment on the in vitro metabolism of aflatoxin and aniline by duck and rat livers.
    Patterson DS; Roberts BA
    Biochem Pharmacol; 1971 Dec; 20(12):3377-83. PubMed ID: 5132884
    [No Abstract]   [Full Text] [Related]  

  • 47. Species susceptibility to aflatoxin B1 carcinogenesis: comparative kinetics of microsomal biotransformation.
    Ramsdell HS; Eaton DL
    Cancer Res; 1990 Feb; 50(3):615-20. PubMed ID: 2105159
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Strain differences in the metabolic activation of aflatoxin B1 in the rat.
    Plummer S; Boobis AR; Davies DS
    Xenobiotica; 1987 Feb; 17(2):199-208. PubMed ID: 3105188
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Reduction in binding of [14C] aflatoxin B1 to rat liver macromolecules by phenobarbitone pretreatment.
    Garner RC
    Biochem Pharmacol; 1975 Aug; 24(16):1553-6. PubMed ID: 1191314
    [No Abstract]   [Full Text] [Related]  

  • 50. Some high-performance liquid-chromatographic studies of the metabolism of aflatoxins by rat liver microsomal preparations.
    Neal GE; Colley PJ
    Biochem J; 1978 Sep; 174(3):839-51. PubMed ID: 728090
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Activation and deactivation of aflatoxin B1 in isolated rat hepatocytes.
    Ch'ih JJ; Lin T; Devlin TM
    Biochem Biophys Res Commun; 1983 Jan; 110(2):668-74. PubMed ID: 6404260
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Liver microsomal metabolism of aflatoxin B 1 to a reactive derivative toxic to Salmonella typhimurium TA 1530.
    Garner RC; Miller EC; Miller JA
    Cancer Res; 1972 Oct; 32(10):2058-66. PubMed ID: 4404160
    [No Abstract]   [Full Text] [Related]  

  • 53. Effects of phenobarbital and beta-naphthoflavone on the activation of cyclophosphamide to mutagenic metabolites in vitro by liver and kidney from male and female rats.
    Hales BF; Jain R
    Biochem Pharmacol; 1980 Jul; 29(14):2031-7. PubMed ID: 6996685
    [No Abstract]   [Full Text] [Related]  

  • 54. The comparative metabolism and toxicokinetics of aflatoxin B1 in the monkey, rat, and mouse.
    Wong ZA; Hsieh DP
    Toxicol Appl Pharmacol; 1980 Aug; 55(1):115-25. PubMed ID: 7423498
    [No Abstract]   [Full Text] [Related]  

  • 55. Effects of phenobarbital and beta-naphthoflavone on the in vivo toxicity and in vitro metabolism of aflatoxin in an aflatoxin-resistant and control line of chickens.
    Manning RO; Wyatt RD; Marks HL
    J Toxicol Environ Health; 1990 Dec; 31(4):291-311. PubMed ID: 2123938
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Induction of lysis in lysogenic bacteria by liver microsomal metabolites of aflatoxin B1.
    Buch JK; Dave PJ
    Indian J Exp Biol; 1980 Oct; 18(10):1162-4. PubMed ID: 6783510
    [No Abstract]   [Full Text] [Related]  

  • 57. Enhancement of hepatic microsome-mediated bacterial mutagenesis by the rat liver soluble protein fraction.
    Saccone GT; Pariza MW
    Mutat Res; 1981 Feb; 88(2):135-45. PubMed ID: 7012606
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Metabolism of food toxicants: saccharin and aflatoxin B1, a contrast in metabolism and toxicity.
    Byard JL
    Adv Exp Med Biol; 1984; 177():147-51. PubMed ID: 6437163
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhibitory effect of phenolic compounds on aflatoxin B1 metabolism and induced mutagenesis.
    San RH; Chan RI
    Mutat Res; 1987 Apr; 177(2):229-39. PubMed ID: 3104775
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Lack of mutagenicity of diphenylhydantoin in in vitro short-term tests.
    Léonard A; de Meester C; Fabry L; de Saint-Georges L; Dumont P
    Mutat Res; 1984; 137(2-3):79-88. PubMed ID: 6433192
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.